Concepedia

H H Oei

HH

5

Publications

522

Citations

5

H-Index

1983

Active since

Affiliations

Novartis (Switzerland)(Current)

H H Oei is an author at Novartis (Switzerland) specializing in pharmacotherapy, medicine, and pharmacology.

Top concepts

Publications per year

1983–2012

5

Publications

5

CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity.

A. Hutchison, Randy L. Webb, H H Oei et al. · Journal of Pharmacology and Experimental Therapeutics · 1989 · 245 citations · Full text

2-(Arylalkylamino)adenosin-5'-uronamides: a new class of highly selective adenosine A2 receptor ligands

Alan Hutchison, Michael Williams, Reynalda de Jesus et al. · Journal of Medicinal Chemistry · 1990 · 120 citations · Full text

, , +16

Urine VCAM-1 as a marker of renal pathology activity index in lupus nephritis

Sandeep Singh, Tianfu Wu, Chun Xie et al. · Arthritis Research & Therapy · 2012 · 117 citations · Full text

Correlation between binding affinities for brain A1 and A2 receptors of adenosine agonists and antagonists and their effects on heart rate and coronary vascular tone.

H H Oei, Geetha Ghai, H. Zoganas et al. · Journal of Pharmacology and Experimental Therapeutics · 1988 · 28 citations

Platelet serotonin uptake during myocardial ischemia

H H Oei, William E. Hughes, Stephen W. Schaffer et al. · American Heart Journal · 1983 · 12 citations

, , +7

Rows per page

1–5 of 5